• National
  • Politics
  • Valley
  • Opinion
  • Money
  • Sports
  • Culture & Lifestyle

  • National
    • Madhesh Province
    • Lumbini Province
    • Bagmati Province
    • National Security
    • Koshi Province
    • Gandaki Province
    • Karnali Province
    • Sudurpaschim Province
  • Politics
  • Valley
    • Kathmandu
    • Lalitpur
    • Bhaktapur
  • Opinion
    • Columns
    • As it is
    • Letters
    • Editorial
    • Cartoon
  • Money
  • Sports
    • Cricket
    • Football
    • International Sports
  • Culture & Lifestyle
    • Arts
    • Brunch with the Post
    • Movies
    • Life & Style
    • Theater
    • Entertainment
    • Books
    • Fashion
  • Health
  • Food
    • Recipes
  • Travel
  • Investigations
  • Climate & Environment
  • World
  • Science & Technology
  • Interviews
  • Visual Stories
  • Crosswords & Sudoku
  • Horoscope
  • Forex
  • Corrections
  • Letters to the Editor
  • Today's ePaper
Saturday, September 20, 2025

Without Fear or FavourUNWIND IN STYLE

24.12°C Kathmandu
Air Quality in Kathmandu: 57
300+Hazardous
0-50Good
51-100Moderate
101-150Unhealty for Sensitive Groups
151-200Unhealthy
201-300Very Unhealthy
Sat, Sep 20, 2025
24.12°C Kathmandu
Air Quality in Kathmandu: 57
  • What's News :

  • Constitution at a critical juncture
  • Reform in major parties
  • Poor market monitoring
  • Repair of offices damaged during protests
  • Art exhibition

World

India gives emergency approval for world's first Covid-19 DNA vaccine

The vaccine, ZyCoV-D, uses a section of genetic material from the virus that gives instructions as either DNA or RNA to make the specific protein that the immune system recognises and responds to. India gives emergency approval for world's first Covid-19 DNA vaccine
Used syringes lie discarded in a bin after they were used to administer the coronavirus disease vaccine in Mumbai, India, August 11, 2021. Reuters
bookmark
  • facebook
  • twitter
  • Whatsapp
  • mail
Reuters
Published at : August 21, 2021
Updated at : August 21, 2021 10:45
Bengaluru

India's drug regulator has granted emergency use approval for Zydus Cadila's Covid-19 vaccine, the world's first DNA shot against the coronavirus, in adults and children aged 12 years and above.

The approval gives a boost to India's vaccination programme, which aims to inoculate all eligible adults by December, and will provide the first shot for those under 18, as the country still struggles to contain the virus spread in some states.

The vaccine, ZyCoV-D, uses a section of genetic material from the virus that gives instructions as either DNA or RNA to make the specific protein that the immune system recognises and responds to.

Unlike most Covid-19 vaccines, which need two doses or even a single dose, ZyCoV-D is administered in three doses.

The generic drugmaker, listed as Cadila Healthcare Ltd, aims to make 100 million to 120 million doses of ZyCoV-D annually and has already begun stockpiling the vaccine.

Zydus Cadila's vaccine, developed in partnership with the Department of Biotechnology, is the second home-grown shot to get emergency authorization in India after Bharat Biotech's Covaxin.

The drugmaker said in July its Covid-19 vaccine was effective against the new coronavirus mutants, especially the Delta variant, and that the shot is administered using a needle-free applicator as opposed to traditional syringes.

The regulatory nod makes ZyCoV-D the sixth vaccine authorized for use in the country where only about 9.18% of the entire population has been fully vaccinated so far, according to Johns Hopkins data.

Zydus Cadila had also submitted data evaluating a two-dose regimen for the shot in July and plans to seek regulatory approval for the same.

The firm had applied for the authorization of ZyCoV-D on July 1, based on an efficacy rate of 66.6% in a late-stage trial of over 28,000 volunteers nationwide.


Related News

Cyberattack disrupts European airports including Heathrow, Brussels
Russian jets enter Estonia’s airspace in latest test for NATO
Trump to impose $100,000 fee per year for H-1B visas, in likely blow to tech
British couple freed by Taliban after Qatari mediation, official says
Feathers fly in dispute over Ambani zoo’s pursuit of rare parrot
US casts 6th veto at United Nations over war in Gaza

Most Read from World

South Korea sees marriages fall by half, births down two-thirds, more foreign spouses
Trump to impose $100,000 fee per year for H-1B visas, in likely blow to tech
Sri Lanka resumes key highway project with $500 million new Chinese funding
Boeing, Honeywell sued by Air India crash victim families
Qatar, US nearing defence deal after Israel's attack in Doha, Rubio says

Editor's Picks

How misinformation fuelled panic during Gen Z uprising
At 86, Spanish Carlos Soria sets sights on Manaslu
She made history as first woman chief justice of Nepal. Now as PM
3 Gorkha youths killed in Gen Z protests, leaving families and dreams shattered
Nepal’s immunisation on the brink after vaccine stocks gutted in arsons

E-PAPER | September 20, 2025

  • Read ePaper Online
ABOUT US
  • About the Post
  • Masthead
  • Editorial Standards & Integrity
  • Workplace Harassment Policy
  • Privacy Policy
READ US
  • Home Delivery
  • ePaper
CONTACT US
  • Write for the Post
  • Letters to the Editor
  • Advertise in the Post
  • Work for the Post
  • Send us a tip
INTERACT WITH US
  • Twitter
  • Facebook
  • Instagram
OUR SISTER PUBLICATIONS
  • eKantipur
  • saptahik
  • Nepal
  • Nari
  • Radio Kantipur
  • Kantipur TV
© 2025 www.kathmandupost.com
  • Privacy Policy
Top